Search

everythinglearnresearchcommunity

for

Search:↓

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

IGFBP-5 likely plays a key role in goat hair growth.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

A new patch can deliver stable antibodies over time for potential HIV treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

The gel effectively delivers EGCG through the skin, improving its absorption.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Mouse high-glycine/tyrosine proteins have distinct patterns in hair follicles, peaking at specific hair cycle days.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

ATP helps prevent skin damage from vandetanib by reducing stress.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.